FDA hands warn­ing let­ters to US, In­di­an man­u­fac­tur­ers over glyc­erin con­t­a­m­i­na­tion

An In­dia-based pro­duc­er of over-the-counter and home­o­path­ic prod­ucts for the US mar­ket has been giv­en a warn­ing let­ter and had all its im­ports halt­ed by the FDA over the pres­ence of the tox­ic ma­te­ri­als di­eth­yl­ene gly­col or eth­yl­ene gly­col.

Cham­pak­lal Ma­g­a­n­lal Homeo Phar­ma­cy Pri­vate Lim­it­ed, a man­u­fac­tur­er based in the city of Ahmed­abad, In­dia, was hand­ed the let­ter on Mon­day af­ter the agency re­viewed records that were sub­mit­ted late last year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER